S. 272 Senate Health
Protect Infant Formula from Contamination Act
STAGE 4 OF 8 — HOUSE FLOOR
Currently in the Senate. Last action: held at the desk on May 4, 2026.
- Senate Introduced in Senate Jan 28, 2025
- Senate Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Jan 28, 2025
- Senate Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably. Jan 15, 2026
- Senate Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute and an amendment to the title. Without written report. Jan 28, 2026
- Senate Placed on Senate Legislative Calendar under General Orders. Calendar No. 306. Jan 28, 2026
- Senate Passed/agreed to in Senate: Passed Senate with an amendment and an amendment to the Title by Unanimous Consent. Apr 28, 2026
- Senate Passed Senate with an amendment and an amendment to the Title by Unanimous Consent. (consideration: CR S2074-2075; text: CR S2074) Apr 28, 2026
- Senate Message on Senate action sent to the House. May 1, 2026
- House Received in the House. May 4, 2026
- House Held at the desk. May 4, 2026
Cosponsors
9
Subjects
Child healthCongressional oversightConsumer affairsFood supply, safety, and labelingGovernment information and archivesManufacturingNutrition and dietSupply chain
Committees
- Health, Education, Labor, and Pensions Committee
- [Reported By, Jan 28, 2026]
- [Markup By, Jan 15, 2026]
- [Referred To, Jan 28, 2025]
- [Referred To, Jan 28, 2025]
Summary
Protect Infant Formula from Contamination ActThis bill imposes certain new requirements on infant formula manufacturers and the Food and Drug Administration (FDA) following the discovery of contaminated, adulterated, or misbranded infant formula. Specifically, the bill requires infant formula manufacturers to report to the FDA within one business day of learning that formula that was processed by the manufacturer but that is no longer within the manufacturer’s control may not provide required nutrients or may be otherwise adulterated or misbranded. Further, if any testing of finished infant formula reveals the presence of specified microorganisms (e.g., salmonella), the manufacturer must notify the FDA within one business day. (Under current law, manufacturers are only required to report contamination to the FDA if the affected formula has left the manufacturer’s control.) The manufacturer must also promptly provide the test results to the FDA and consult with the FDA on proper isolation and disposal of the affected product. The FDA must respond to such a notification and begin discussing proper investigative and corrective action with the manufacturer within one business day. Within 90 days of a report of adulterated, misbranded, or contaminated infant formula, the FDA must determine whether the manufacturer that reported the problem has performed, or is performing, appropriate investigative and corrective action. Finally, the FDA is required to periodically report on the infant formula supply chain and efforts to improve the safety and supply of infant formula, and must consult with other federal agencies and infant formula stakeholders on these issues.
[Summary as of: Introduced in Senate]
Comments · 0
Please log in to post a comment.
Loading comments...